Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Novartis Ireland Limited naming Simon Harris .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | Novartis Ireland Limited | Health | Forwarding letter to Dept of Health about access to innovative treatment for Irish patients (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2025 | Novartis Ireland Limited | Health | Advocate for Life Science Strategy (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | Health | Letter to Tanaiste about access to innovative treatment for Irish patients (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | Health | Rare diseases conference, as an official event of the Irish EU Presidency (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | Health | IPHA Industry meeting - engagement on trade and tariff issues (Legislation) | 1 | On lobbying.ie |
| May–Aug 2017 | Novartis Ireland Limited | Health | Highlight delay in reimbursing Entresto (Heart Failure medine), the first new innovation in heart failure in a decade considered cost effective in July 2016 (Matters involving public funds) | 23 | On lobbying.ie |
| May–Aug 2016 | Novartis Ireland Limited | Health | Ensure that the 2016 Framework Agreement on the Pricing and Supply of Medicines is resolved by aggreement, not legislation (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 7 | 100.0% |